References
- 통계청. 1999년 장래 인구 추계. 2001
- Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W,Cooke TD, Greenwald R, Hochberg M.Development of criteria for the classification and reporting of osteoarthritis : classification of osteoarthritis of the knee. Arthritis Rheum 1986; 29(8): 1039-1049 https://doi.org/10.1002/art.1780290816
- 오정열, 조경환. 노인환자케서의 골관절염. 가정의학회지 1998; 19(11): 1129 -1135
- 정수태, 강봉균. 골판절염의 원인과 치료. 가정의학회지 2000; 21(11): S824-S827
- Lee CK. Osteoarthritis. Korean J Med 2000; 59(2):246-249 (Korean)
- Brandt KD. Management of osteoarthritis, In : Kelly WN, Ruddy S, Harris ED, Sledge CB. Textbook of rheumatology, 5th ed. p.1394 , philadepmι W.B. Saun ders,1997
- Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T,Whelton A, Makuch R, Eisen G, Agrawal NM, Stenson WF, Burr AM, Zhao WW, Kent JD, Lefkowith JB, Verburg KM, Geis GS. Gastrointestional toxicity with celecoxib vs nonsterio dal anti-inflammatory drugs for oste oarthritis and rheumatoid arthritis: the ClASS study: A ramdomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 2000; 284(10); 1247-1255
- Goldstein JL, Silverstein FE, Agrawal NM, Hubbard RC, Kaiser J, Maurath CJ, Verburg KM, Geis GS. Reduced risk of upper gastrointestional ulcer complications with celecoxib, a novel COX-2 inhibitor. Am J Gastroenterol 2000; 95(7): 1681-1690 https://doi.org/10.1111/j.1572-0241.2000.02194.x
- Traversa G, Walker AM, Ippolito FM, Caffari B, Capurso L, Dezi A, Koch M, Maggini M, Alegiani SS, Raschetti R. Gastroduodenal toxicity of different non steroidal antiinflammatory drugs. Epidemiology 1995; 6(1): 49-54 https://doi.org/10.1097/00001648-199501000-00010
- 통계청. 한국표준질병사인분류. 1993
- Goodman, Gilman. Goodman & Gilman's the pharmacological basis of therapeutics 9th ed., pp621
- Ausiello JC, Stafford RS. Trend in medication use for osteoartjrotos treatment. J Rheumatol 2002; 29(5): 999-1005
- Bradley JD, Brandt KD, Katz BP, Kalasinski LA, Ryan SI. Comparison of an antii-inflamrnatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee. NEJM 1991; 325(2): 87-91 https://doi.org/10.1056/NEJM199107113250203
- Brandt KD. Should osteoarthritis be treated with nonsteroidal anti-inflammatory drugs? Rheum Dis Clin North Am. 1993; 19(3): 697-712
- Brandt KD, Bradley JD. Should the initial drug be used to treat osteoarthritis pain be a nonsteroidal anti-inflammatory drug? J Rheumatol. 2001; 28(3): 467 -473
- Hochberg MC, Altman RD, Brandt KD, Clark BM, Dieppe PA, Griffin MR, Moskowitz RW, Schnitzer TJ. Guidelines for the medical management of osteoar thritis: I. Osteoarthritis of the hip. Arth ritis Rheum 1995; 38(11): 1535-1540 https://doi.org/10.1002/art.1780381103
-
Hochberg MC, Altman RD, Brandt KD, Clark BM, Dieppe PA, Griffin MR, Moskowitz RW, Schnitzer TJ. Guidelines for the medical management of osteoarthritis:
$\Pi$ . Osteoarthritis of the knee. Arthritis Rheum 1995; 38(11): 1541-1546 https://doi.org/10.1002/art.1780381104 - Cho HJ, Woo SK, Honh CT, Seo YK. Comparison of prescription behaviors between practicing physicians and pharmacists by simulated patients of arthritis. J Korean Acad Fam Med 2001; 22(4) 511-516 (Korean)
- Ward K, Weir DG. Piroxicam and upper gastrointestinal haemorrhage. Ir Med J. 1982; 75(1): 10-11
- Giercksky KE. Piroxicam and gastrointestinal bleeding. Am J Med. 1986; 81 (5B): 2-5
- Lipscomb GR, Wallis N, Armstrong G, Rees WD. Gastrointestinal tolerability of meloxicam and piroxicam: a double-blind placebo-controlled study. Br J Clin Phar macol. 1998;46(2): 133-137 https://doi.org/10.1046/j.1365-2125.1998.00761.x
- Fries JF, Williams CA, Bloch DA. The ralative toxicity of nonsteroidal antiinflammatory drugs. Arthritis Rheum 1991; 34(11): 1353-1360 https://doi.org/10.1002/art.1780341103
- 이상현 관절염 약물 선택지침: 골관절염과 류마티스 관절영을 중심으로 가정의학회지 1998; 19(5) :S240-S251
- Needleman P, Isakson PC. Selective inhibition of cylooxygenase 2. Scihed & Med. 1998;Jan/Feb: 26-35
- Mukherjee D, Nissem SE, Topol EJ. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 2001; 286(8): 954-959 https://doi.org/10.1001/jama.286.8.954
- IMS Health. National disease and therapeutics index, Disease report, Forth quarter 2000, p.1538. Plymonth Meeting. PA:IMS HEALTH2001
- 한석원, 윤종구. 위십이지장 궤양의 원인 및 병태생리-NSAIDs 및 기타 원인-. 대 한소화기내시경학회세미나 1998
- Manek NJ. Medical Management of Osteoarthritis. Mayo Clin Proc 2001; 76(5): 533-539 https://doi.org/10.4065/76.5.533
- Johnson AG, Seidemann P, Day RO. NSAID-related adverse drug interactions with clinical relevance. Int J Clin Pharmacol Ther. 1994; 32(10): 509-532
- Wallance JL. Prostaglandins, NSAIDs and cytoprotection. Gastroenterol Clin North Am 1992; 21(3): 631
- 박병주, 성주헌, 박기동, 서순원, 김세화. 건강보험 질병코드의 타당도 제공방안 및 자료의 활용방안 수립. 2002년 용역과 제결과보고서 2003